Name: UMIN ID:
Unique ID issued by UMIN | UMIN000028447 |
---|---|
Receipt number | R000032563 |
Scientific Title | Phase II Trial of Apixaban in Japanese Patients with Cancer-Associated Venous Thromboembolism |
Date of disclosure of the study information | 2017/08/01 |
Last modified on | 2022/06/07 20:49:03 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/07/31 01:18:16 | ||
2 | Update | 2017/10/20 20:55:00 | Email1 |
|
3 | Update | 2017/11/13 23:24:08 | Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
4 | Update | 2017/11/13 23:25:08 | Date of protocol fixation Anticipated trial start date |
|
5 | Update | 2017/12/05 01:27:43 | Key exclusion criteria Key exclusion criteria |
|
6 | Update | 2017/12/05 01:28:23 | Date of protocol fixation Anticipated trial start date |
|
7 | Update | 2018/01/31 22:08:06 | Date of protocol fixation |
|
8 | Update | 2018/03/09 11:20:55 | Recruitment status Anticipated trial start date |
|
9 | Update | 2019/09/29 19:04:12 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
10 | Update | 2022/06/07 20:49:03 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Institute Department Organization Division Organization Organization Address Address Tel |